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Abstract
Background: Several mutations have been described as responsible for rifampicin resistance in Neisseria meningitidis.
However, the intriguing question on why these strains are so rare remains open. The aim of this study was to
investigate the protein content and to identify differential expression in specific proteins in two rifampicin resistant
and one susceptible meningococci using two-dimensional electrophoresis (2-DE) combined with mass spectrometry.
Results: In our experimental conditions, able to resolve soluble proteins with an isoelectric point between 4 and 7,
twenty-three proteins have been found differentially expressed in the two resistant strains compared to the
susceptible. Some of them, involved in the main metabolic pathways, showed an increased expression, mainly in
the catabolism of pyruvate and in the tricarboxylic acid cycle. A decreased expression of proteins belonging to
gene regulation and to those involved in the folding of polypeptides has also been observed. 2-DE analysis
showed the presence of four proteins displaying a shift in their isoelectric point in both resistant strains, confirmed
by the presence of amino acid changes in the sequence analysis, absent in the susceptible.
Conclusions: The analysis of differentially expressed proteins suggests that an intricate series of events occurs in
N. meningitidis rifampicin resistant strains and the results here reported may be considered a starting point in
understanding their decreased invasion capacity. In fact, they support the hypothesis that the presence of more
than one protein differentially expressed, having a role in the metabolism of the meningococcus, influences its
ability to infect and to spread in the population. Different reports have described and discussed how a drug
resistant pathogen shows a high biological cost for survival and that may also explain why, for some pathogens,
the rate of resistant organisms is relatively low considering the widespread use of a particular drug. This seems the
case of rifampicin resistant meningococci.
Background
Management of meningococcal disease requires immedi-
ate treatment of patients and chemoprophylaxis of con-
tacts. For the latter, rifampicin is the most frequently
used antibiotic. However, although it has been utilized
routinely worldwide for more than 30 years, few cases
of rifampicin resistant meningococci have been reported
[1]. This scarce diffusion is intriguing and the reduced
virulence of these strains in terms of the bacterium’s
survival in the bloodstream of mice, as shown in an in
vivo model, suggests a major biological cost for the
microorganism [2].
The resistance phenotype is correlated with a set of
mutations in the rpoB gene, encoding the b subunit of
RNA polymerase, resulting in amino acid substitutions
at one of the following codons: Asp542, Ser548, His552,
Ser557, Gly560 [3-6]. Moreover, other mechanisms have
been described in both Neisseria meningitidis and in
Neisseria gonorrhoeae [7,8], i.e. resistance to diverse
hydrophobic agents, including Triton X, is associated
with mutations in the mtrR gene and in its promoter
[7,9,10]. Overall, in other species, such as Mycobacter-
ium tuberculosis, resistance was not related to any
changes in the rpoB gene in around 5% of clinical rifam-
picin resistant isolates [11]. Rifampicin binds to DNA-
dependent RNA polymerase and inhibits initiation of
RNA synthesis which is not a mechanism of action
shared with other antibiotics. This effect on RNA poly-
merase appears to result from drug binding in the
* Correspondence: paola.stefanelli@iss.it
1Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto
Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
Full list of author information is available at the end of the article
Neri et al. BMC Microbiology 2010, 10:246
http://www.biomedcentral.com/1471-2180/10/246
© 2010 Neri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.polymerase subunit deep within the DNA/RNA channel
where direct blocking of the elongating RNA can occur.
Little is known of the protein expression of N. menin-
gitidis resistant to rifampicin and how this contributes
to pathogenesis. In the present study, soluble proteins of
two rifampicin resistant and one susceptible meningo-
cocci isolated in Italy, and previously described [5], were
analysed by two-dimensional electrophoresis (2-DE)
combined with mass spectrometry (MALDI-ToF). The
method has been chosen because it is a comprehensive
approach to investigate the protein content of a patho-
gen [12], and in this context helpful to identify differen-
tial expression in specific proteins in particular in
rifampicin resistance meningococci.
Methods
Bacterial strains and bacterial proteins extraction
Two rifampicin resistant (RIF
R) 870 and 901 strains and
one rifampicin susceptible (RIF
S) 1958 serogroup C
meningococci were analysed. The resistant strains
showed two already described [5] mutations in the rpoB
gene, the Asp542Val and the His552Tyr. Strain 870 had
caused fatal septicaemia in a 34 year-old man and strain
901, meningitis in a 1 year-old infant. The RIF
S 1958
invasive strain was responsible for septicaemia in an
infant aged 2, and since the absence of mutations in the
rpoB gene, was chosen as control strain.
Bacterial protein extraction was performed according to
the protocol previously described [13], with some modifi-
cations. In particular, the confluent bacterial growth was
scraped from the plates and washed twice with PBS, sus-
pended in 5 ml of lysis buffer (500 mM NaCl, 10 mM
EDTA, 50 mM Tris pH 8.0) containing 0.3 mg/ml pro-
tease inhibitor (CompleteMini, Roche Diagnostic, Man-
nheim, Germany) and 150U DNase I (Roche Diagnostic).
T h es a m p l ea n a l y s e db y2 - D Ea p p r o a c hc o r r e s p o n d s
to the cytosolic fraction, in which most of the proteins
involved in the metabolic pathway and in essential bio-
logical processes have been described in bacteria.
Two-dimensional gel electrophoresis
Before electrophoresis an aliquot of protein extract cor-
responding to 350 μg of each sample was precipitated
by adding nine volumes of cold-ethanol and keeping at
-20°C overnight. Samples were centrifuged at 14. 000 g
for 15 min at 4°C and pellets were dried and then dis-
solved in 185 μl of a rehydration buffer containing 7 M
urea, 2 M thiourea, 2% w/v CHAPS, 50 mM DTT, 0.2%
v/v Bio-Lytes™pH range 3-10. Each sample was loaded
on an 11-cm precast Immobiline strip with a linear pH
4-7 gradient and three replica maps were performed.
First- and second-dimension electrophoresis, and image
analysis were carried out as already described by
Mignogna et al. [13].
Protein identification
Spots selected according to the procedure previously
described [13], were manually excised from gels and
digested with trypsin. Digestion was performed at 37°C
overnight. Briefly, after several destaining steps using 50
mM ammonium bicarbonate (15 min), 50% acetonitrile
in 50 mM ammonium bicarbonate (10 min) and 100%
acetonitrile (15 min), subsequently, about 100 ng of
trypsin (Trypsin Gold, Mass Spectrometry Grade, Pro-
mega, Madison, WI, USA), solubilised in 10 μlo fa2 5
mM ammonium bicarbonate digestion buffer, were
added to vacuum-dried gel.
An aliquot (1 μl) of each mixture peptide was mixed
w i t ht h es a m ev o l u m eo fa-cyano-4-hydroxy-trans-cin-
namic acid matrix solution (5 mg/ml) in 70% acetoni-
trile containing 0.1% TFA (v/v) for MALDI-ToF
analysis, performed in a Voyager-DE STR instrument
(Applied Biosystems, Framingham, MA) equipped with
a 337 nm nitrogen laser and operating in reflector
mode. Mass data were obtained by accumulating several
spectra from laser shots with an accelerating voltage of
20 kV. Two tryptic autolytic peptides were used for the
internal calibration (m/z 842.5100 and 2807.3145).
Identification by peptide mass fingerprint (PMF), was
performed using the Mascot search engine version 2.2
[14] against NCBlnr database (10386837 sequences). Up
to one missed cleavage, 50 ppm measurement tolerance,
oxidation at methionine (variable modification) and car-
bamidomethyl cysteine (fixed modification) were consid-
ered. Post-translational modifications were not taken
into account. Identifications were validated when the
probability-based Mowse protein score was significant
according to Mascot [15].
Statistical analysis of 2-DE maps
For gel comparison, a statistical approach was applied
when determining differentially expressed proteins using
the PDQuest software (version 7.2.0, BioRad). Student’s t-
test was performed with 90% significance level to deter-
mine which proteins were differentially expressed between
the susceptible and resistant strain. Thresholds for assign-
ing differential expression between the two pools were
setat a minimum 2-fold change for up-regulation and
0.5-fold for down-regulation. This fold change threshold
was chosen to obtain significant changes in protein
expression. To minimize variation due to experimental
factors, the intensity of each spot was normalized on
the basis of the total integrated optical density for the
examined gel.
Sequence analysis of the genes encoding the four shifted
proteins
Chromosomal DNAs were extracted by using the
QIAamp DNA mini kit (Qiagen, Hilden, Germany)
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encoding genes for the four shifted proteins of the
meningococcal isolates were amplified by PCR and
sequenced with primers designed on conservative
regions of corresponding genes from N. meningitidis
FAM18 (NCBI accession number AM421808) (Table 1).
All reactions were carried out with 100ng of purified
chromosomal DNA, 5 μl of 10× reaction buffer, 0.01
mM of dNTP solution (Finnzymes, Finland), 2.5U Hot-
StartTaq (Qiagen), 25pmol of each primer and sterile
water to a final volume of 50 μl. Three different cycle
conditions, changing for the annealing temperatures,
were set up for the putative oxidoreductase, putative
phosphate acyltransferase, putative zinc-binding alcohol
dehydrogenase genes, respectively. In particular, 95°C
for 15 minutes (hot-start); 30 cycles of 95°C for
30 seconds, 54°C -55°C-58°C for 30 seconds, and 72°C
for 1 minute; and a final extension reaction at 72°C for
7m i n u t e s .
Cycle conditions for the isocitrate dehydrogenase gene
were set at 95°C for 15 minutes (hot-start); 30 cycles of
95°C for 30 seconds, 58°C for 30 seconds, and 72°C for
2 minutes; a final extension reaction at 72°C for 7
minutes.
The PCR products were analysed using the BLAST
program http://www.ncbi.nlm.nih.gov/BLAST/; amino
acid sequences were aligned using the ClustalW pro-
gram http://www.ebi.ac.uk/clustalw/.
Analysis of N. meningitidis rifampicin resistant and
susceptible strains growth curves
Meningococcal strains were incubated overnight on GC
agar base (Oxoid, Basingstoke, UK) plates at 37°C with
5% CO2. Isolated colonies were inoculated in 4 ml GC
broth plus rifampicin slightly stirring. The broth suspen-
sions were immediately adjusted to an initial OD600 of
0.08 and the growth was measured by reading optical
density (OD) every 60 min.
The RIF
R strains were grown on plates with 50 μg/ml
of rifampicin. Each growth curve was repeated three
times.
Results
Analysis of protein expression by 2-DE
The 2-DE gels were performed in three replicates and
variations in spot intensity were confirmed by statistical
analysis. Representative 2-DE maps of the two RIF
R 870
and 901 strains and one RIF
S 1958, are reported in fig-
ure 1A. The number of detected spots was in a range of
320 to 450 for all replicates.
A ss h o w ni nf i g u r e1 A ,t h e r ew a sah i g hs i m i l a r i t yi n
protein pattern among the resistant and susceptible
strains, with the majority of proteins ranging from pI 4
to 6 and with a molecular weight from 6000 to 195000
Da.
Protein identification by 2-DE gels and relative expres-
sion data were compared using PDQuest software; spots
with a minimum of 2-fold change were chosen to define
an up-expressed protein and 0.5-fold to define a down-
expressed protein.
A total of twenty-three spots were found to be differ-
entially expressed in both rifampicin resistant strains
compared to the susceptible; all of them were subjected
to the peptide mass fingerprinting (PMF) by MALDI-
ToF analysis for protein identification. We performed
the same analysis also on two isogenic rifampicin resis-
tant meningococci mutants: the reference strain
N. meningitidis serogroup B MC58 and one clinical
isolate (data not shown).
Table 2 shows the functional classification of 23 up-
and down-expressed proteins according to Universal
Protein Knowledgebase (UniProtKB) database [16].
Proteins belonging to the carbohydrate metabolism
and the enzymes involved in the reactions of the tricar-
boxylic cycle (TCA) resulted up-expressed: in particular,
the phosphenolpyruvate synthase [A1KSM6], the pyru-
vate dehydrogenase subunit E1 [A1KUG5], the gluta-
mate dehydrogenase [A1KVB4], together with the
isocitrate dehydrogenase [A1KTJ0], the succinyl-CoA
synthetase subunit beta [A1KTM6] and the aconitate
hydratase [A9M175]. Four proteins belonging to differ-
ent metabolic pathways and those responsible for ATP
production were down-expressed in both resistant
Table 1 Primers for amplification and sequence analyses of genes encoding the four shifted proteins found in
rifampicin resistant meningococci
Primer Sequence (5’®3’) Protein encoded (Locus tag)
ADZ-f
576170GCGTTTCAGACGGCATTTGT
576189* putative zinc-binding alcohol dehydrogenase (NMC0547)
ADZ-r
577320GCCAGATTCAGACGGTATTCC
577300*
ICD-f
893762ACGACGAATGTTCAGACGG
893780* isocitrate dehydrogenase (NMC0897)
ICD-r
896097TGCCATAATAGCCACGCAC
896079*
PTA-f
607259AAGCCGTTTGTCAGCCTT
607276* putative phosphate acyltransferase Pta (NMC0575)
PTA-r
608401CGGGCGTATTGGAAGGTTT
608383*
POX-f
445746AAAGCCGGATAAGTGGGAAC
445765* putative oxidoreductase (NMC0426)
* the position referring to the corresponding accession number of N. meningitidis strain FAM18, accession number AM421808.
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the enolase [A1KUB6], the putative zinc-binding alcohol
dehydrogenase [A1KSL2], the carboxyphosphonoenol
pyruvate phosphonomutase[ A 9 M 2 G 6 ]a n dt h eF 0 F 1
ATP synthase subunit a [A9M121 (Table 2).
As e c o n dg r o u po fp r o t e i n si si n v o l v e di nt h er e g u l a -
tion of the gene expression: the elongation factor G
[A1KRH0], the transcription elongation factor NusA
[C9WY90], and the DNA-directed RNA polymerase sub-
unit a [A1KRJ9] were up-expressed. On the contrary, the
DNA-binding response regulator [A9M2D6], involved in
the transcription, the trigger factor [A1KUE0] involved
in protein export, the 60 kDa chaperonin [A1KW52],
that prevents misfolding and promotes the refolding of
polypeptides, and the peptidyl-prolyl cis-trans isomerase
[A9M3M5], which accelerates the folding of proteins,
were down-expressed.
The cell division protein [A1KVK9], the septum site-
determining protein MinD [A9M3T7], the malonyl-CoA-
acyl carrier protein transacylase [A1KRY7] and the putative
oxidoreductase [A9M1W2], also resulted down-expressed.
Four of the 23 listed proteins in the Table2 had a dif-
ferent pI in both the resistant strains. The difference in
the pI was well visualised in the 2-DE gels. As shown in
figure 1B, the isocitrate dehydrogenase (spot 5) and the
putative zinc-binding alcohol dehydrogenase (spot 15)
were shifted to a more basic pI, while the putative phos-
phate acetyltransferase (spot 9) and the putative oxidor-
eductase (spot 23) were shifted to a more acidic pI.
Sequence analysis of the genes encoding the shifted
proteins
The four genes encoding proteins with a different pI
were sequenced. In particular, NMC0426, NMC0547,
Figure 1 2-DE of proteins corresponding to cytosolic fractions from (A) rifampicin resistant 870 and 901 and rifampicin susceptible
1958 N. meningitidis strains; (B) close-up views of some protein spots differentially expressed; spot numbers correspond to those
reported in the panel A.
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Spot n Protein name (gene)
a Protein
accession
number
Ordered
Locus
Name
b
Sequence
coverage
%
Mowse
Score
MWt/pIt Expression
level
c
UniProtKB
Functional classification
d
1 Aconitate hydratase (acnB) A1KUZ6 NMC1492 51 403 93412/5.38 up Carbohydrate metabolism:
TCA cycle
2 Piruvate dehydrogenase
subunit E1 (aceE)
A1KUG5 NMC1278 53 426 99915/5.60 up Carbohydrate metabolism:
pyruvate metabolism
3 Putative
phosphoenolpyruvate
synthase (ppsA)
A1KSM6 NMC0561 26 165 87128/6.01 up Carbohydrate metabolism:
pyruvate metabolism
4 Elongation factor G (fusA) A1KRH0 NMC0127 30 245 77338/5.08 up Genetic Information
Processing: protein
synthesis
5 Isocitrate dehydrogenase (icd) A1KTJ0 NMC0897 27 229 80313/5.53 up* Carbohydrate metabolism:
TCA cycle
6 60 kDa chaperonin (groL) A1KW52 NMC1948 41 206 57535/4.90 down Genetic Information
Processing: protein folding
7 ATP synthase subunit a
(atpA)
A1KW13 NMC1908 62 281 55481/5.50 down Energy metabolism:
oxidative phosphorilation
8 N utilisation substance
protein A (nusA)
A1KV50 NMC1556 71 426 55745/4.54 up Genetic Information
Processing: protein
synthesis
9 Putative phosphate
acyltransferase (NMC0575)
A1KSN9 NMC0575 47 263 57551/5.47 up* Carbohydrate metabolism:
propanoate metabolism
10 Probable malate:quinone
oxidoreductase (mqo)
A1KWH2 NMC2076 36 178 54091/5.58 down Carbohydrate metabolism:
TCA cycle
11 Trigger factor (tig) A1KUE0 NMC1250 51 209 48279/4.76 down Genetic Information
Processing: protein folding
12 Enolase (eno) A1KUB6 NMC1220 25 129 46319/4.78 down Carbohydrate metabolism:
glycolysis
13 Cell division protein (ftsA) A1KVK9 NMC1738 40 132 44348/5.33 down Genetic Information
Processing: cell division
14 Glutamate dehydrogenase
(gdhA)
A1KVB4 NMC1625 54 221 48731/5.80 up Energy metabolism: amino
acid metabolism
15 Putative zinc-binding alcohol
dehydrogenase (NMC0547)
A1KSL2 NMC0547 38 235 38283/5.32 down* Carbohydrate metabolism:
butanoate metabolism
16 Succinyl-CoA ligase [ADP-
forming] subunit beta (sucC)
A1KTM6 NMC0935 26 125 41567/5.01 up Carbohydrate metabolism:
TCA cycle
17 DNA-directed RNA
polymerase subunit a (rpoA)
A1KRJ9 NMC0158 41 184 36168/4.94 up Genetic Information
Processing: transcription
18 Carboxyphosphonoenol
pyruvate phosphonomutase
(prpB)
A1KVK6 NMC1733 73 234 31876/5.22 down Carbohydrate metabolism:
propanoate metabolism
19 Putative malonyl Co-A acyl
carrier protein transacylase
(fabD)
A1KRY7 NMC0305 57 158 31958/5.44 down Lipid metabolism: fatty acid
biosynthesis
20 Septum site-determining
protein (minD)
A1KRK2 NMC0161 29 143 29768/5.70 down Genetic Information
Processing: cell division
21 Putative two-component
system regulator (NMC0537)
A1KSK4 NMC0537 74 181 24821/5.44 down Environmental Information
Processing: signal
transduction
22 Peptidyl-prolyl cis-trans
isomerase (ppiB)
A1KT50 NMC0744 84 260 18840/5.04 down Genetic Information
Processing: protein folding
23 Putative oxidoreductase
(NMC0426)
A1KSA1 NMC0426 52 129 20759/5.74 down* -
a According to the UniProtKB/TrEMBL entry http://www.uniprot.org/.
bOrdered Locus Name in Neisseria meningitidis serogroup C/serotype 2a (strain ATCC 700532/FAM18).
c Expression level of RIF
R versus RIF
S strains.
d Functional classification of the proteins according to KEGG: Kyoto Encyclopedia of Genes and Genomes http://www.genome.jp/kegg/.
*Protein with changed pI in RIF
R versus RIF
S isolate.
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Page 5 of 8NMC0575 and NMC0897 genes of the two resistant
strains showed nucleotide mutations resulting in amino
acid changes absent in the susceptible strain. All of
them were considered missense mutations: 1) an argi-
nine was replaced by a histidine residue at position 21
in the putative oxidoreductase; 2) an aspartic acid was
replaced by a glycine residue at position 81 in the puta-
tive zinc-binding alcohol dehydrogenase; 3) an alanine
was replaced by a serine residue at position 331 and an
arginine by a leucine at position 351 in the putative
phosphate acetyltransferase; 4) a threonine was replaced
by an alanine residue at position 166; an isoleucine by a
threonine at position 189; a glutamic acid by an alanine
at position 212; an aspartic acid by a glycine at posi-
tion 284; a valine by an alanine at position 710 and a
v a l i n eb ya na l a n i n ea tp o s i t i o n7 3 1i nt h ei s o c i t r a t e
dehydrogenase.
Analysis of bacteria growth curves
The rifampicin resistant strains grew normally and
showed the same colony appearance as the rifampicin
susceptible isolate, on GC agar plates with the naked eye
or with a light microscope (data not shown). As shown in
figure 2, after GC broth inoculation, there were differ-
ences in growth between the susceptible and resistant
strains from the starting point of the inoculation (T0) to
the stationary phase. In particular, the growth of the
resistant strains showed primarily a delay in the onset of
the logarithmic phase compared with the susceptible
strain with different maximal OD600 =0 . 8 2o f1 9 5 8 ,
OD600 = 0.7 of 901, OD600 = 0.65 of 870 (figure 2).
Discussion
As a transformable bacterium Neisseria meningitidis is
incline to acquire exogenous bacterial DNAs, but it has
been relatively slow to acquire resistance. However,
since it is a severe disease it is very important to moni-
tor changes in the level of antibiotic susceptibility
among clinical isolates. Resistance to rifampicin is only
occasionally observed but the isolation of a resistant
strain poses serious problems in managing the prophy-
laxis of close contacts. At present, it is unknown how
changes in resistant phenotype correspond to different
protein expression profiles.
Some studies reveal that the molecular mechanism of
resistance is correlated to different amino acid changes
in a short central region of the rpoBg e n ee n c o d i n gt h e
b-subunit of the RNA polymerase [3,17]. Moreover, a
scarce virulence of rifampicin resistant N. meningitidis
isolates has been proved in an in vivo model [2].
It is interesting to focus on adaptation mechanisms
under antibiotic challenge which have a cost in terms of
fitness [18]. The results described in this paper permit
to hypothesize that compensation for the rifampicin
resistance phenotype may be responsible for the differ-
ent protein expression in meningococcus. The phenom-
enon is not so rare among bacterial pathogens and the
proteomic approach facilitates the comprehensive
Figure 2 Growth curves in GC broth of rifampicin resistant and susceptible strains. Error bars represent the standard deviation of three
culture replicates.
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ered in the 2-DE maps belong to the cytosolic fraction.
The latter permits to analyse differences in those pro-
teins involved in metabolic pathways including the RNA
polymerase, as the molecular target of rifampicin resis-
tance. On the basis of the catalogue of proteins of the
reference N. meningitidis strain MC58 [13], protein
expression in two rifampicin resistant and one suscepti-
ble meningococci was analysed.
The proteomic approach allows us to define the differ-
ences in protein pathways compared to the protein set
of rifampicin susceptible meningococci.
In our experimental conditions the soluble proteins
obtained between pI 4 and 7 were identified in the dif-
ferent set of metabolic pathways. In particular, the
results revealed a decrease of proteins, such as the 60
kDa chaperonin, trigger factor and peptidyl-prolyl cis-
trans isomerase, involved in the accurate folding of poly-
peptides. Such results suggest that the bacteria may
direct their metabolism towards the production of new
polypeptide chains with a high energy cost.
Moreover, the proteins involved in crucial metabolic
pathways showed an increased expression with particu-
lar regard to the catabolism of the pyruvate: the phos-
phoenolpyruvate synthase, involved in the conversion of
pyruvate into phosphoenolpyruvate, and the pyruvate
dehydrogenase subunit E1, that catalyzes the pyruvate
decarboxylation into acetyl-CoA. Pyruvate is a key inter-
section in several metabolic pathways in bacteria [19],
and so the altered expression of its catabolites may be
reflected in the different pathways it generates. Three
proteins, the putative phosphate acyltransferase, the car-
boxy phosphoenol pyruvate phosphomutase and the
putative zinc-binding alcohol dehydrogenase, involved in
the TCA cycle, gluconeogenesis and oxidation reaction,
were differentially expressed. Similarly to the pyruvate,
the acetyl-CoA too is an important molecule in the bac-
terial metabolism, since it is the starting point of many
biochemical reactions [20]. Its main use is to convey the
carbon atoms within the acetyl group to the TCA cycle
to be oxidized for energy production. In this oxidative
direction the two rifampicin resistant isolates showed an
up-expression of the three main proteins of the TCA
cycle: the aconitate hydratase, the isocitrate dehydrogen-
ase and succinyl-CoA synthetase subunit beta. These
results were in agreement with findings in a comparative
study on resistant Acinetobacter baumannii [21].
The glutamate dehydrogenase, one of the essential
enzymes for meningococcal pathogenesis in the infant
rat model [22], was also up-regulated; this is of particu-
lar relevance since it belongs to the amino acid
biosynthesis.
One of the advantages of the proteomic approach is
that protein modifications that lead to changes in charge
or size can directly be visualized [23]. In fact, four pro-
teins in both resistant strains displayed a shift in their
pI. The pI shifts were confirmed by the presence of
amino acid changes due to missense mutations. In parti-
cular, the substitution of the cationic amino acid argi-
nine with the neutral leucine was responsible for the
acidic shift of putative phosphate acetyltransferase. On
the other hand, the basic shift of putative zinc-binding
alcohol dehydrogenase and isocitrate dehydrogenase was
due to mutations of aspartic acid and glutamic acid to
neutral ones. It is noteworthy that the two rifampicin
resistant strains showed a different growth curve with a
longer lag phase compared to t h es u s c e p t i b l ei s o l a t e .
The analysis revealed that most differences in protein
expression patterns were genetically encoded rather
than induced by antibiotic exposure. Over-expression of
stress proteins was expected, as they represent a com-
mon non-specific response by bacteria when stimulated
by different shock conditions. Positive transcription reg-
ulators were found to be over-expressed in rifampicin
resistance, suggesting that bacteria could activate com-
pensatory mechanisms to assist the transcription process
in the presence of RNA polymerase inhibitors. Other
differences in expression profiles were related to pro-
teins involved in central metabolism; these modifications
suggest metabolic disadvantages of resistant mutants
compared to sensitive ones. Of particular interest are
the proteins involved in the cell division site. The
altered proteins can affect the integrity of the Z ring at
various stages. In the same way, it was hypothesized
that the Z ring assembly could be both coordinated with
the cell cycle and rendered responsive to cellular and
environmental stresses.
The analysis of the protein differentially expressed
may suggest the intricate series of events occurring in
these strains. In this light, the growth results may be
partially explained by a decrease expression of proteins
such as the cell division protein and the septum site-
determining protein MinD.
Conclusions
Our findings reveal that we need a deeper understand-
ing of the interplay between antibiotic resistance, biolo-
gical fitness and virulence. Although our results are not
sufficient to establish an unequivocal association
between the differential protein expression and the
resistant phenotype, they may be considered a starting
point in understanding the decreased invasion capacity
of
N. meningitidis rifampicin resistant strains. In fact, they
support the hypothesis that the presence of more than
one protein differentially expressed, having a role in the
metabolism, influences the ability to infect and to spread
in the population. Different reports have described and
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biological cost for survival [24,25] and that may also
explain why, for some pathogens, the rate of resistant
organisms is relatively low considering the widespread
use of a particular drug. This seems the case of rifampi-
cin resistant meningococci.
Only the combination gained from different experi-
mental methods and clinical data reporting will enable
to model the adaptation response of such strains in
their physiological network. Our aim was to improve
knowledge of the microbial physiology of resistant
meningococci and understand why, despite widespread
use of rifampicin in prophylactic treatment, the resistant
isolates continue to be so rare.
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